Malaysian Genomics Grows Presence in Thailand
2022年9月23日 - 3:00PM
JCN Newswire
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a
leading genomics and biopharmaceutical specialist, is pleased to
announce today a series of collaborations to grow its customer base
in Thailand as well as exploring opportunities for research and
development (R&D) of new products and services.
The Group signed a supply and collaboration agreement with Acquest
Healthcare Stem Cell Research and Development Co. Ltd. to produce
CAR T-cells for supply to Acquest's customers. Acquest is a
well-established provider of various cell therapies to hospitals,
specialist doctors, and patients in Thailand. It operates a
state-of-the-art clinical laboratory and also the largest
privately-owned specialty human cell culturing facility in the
country.
The Group also signed a supply and collaboration agreement with
Salus Holdings Co. Ltd. ("Salus") to supply biopharmaceutical and
genomics products and services to Salus' customers. Salus is a
specialist in wellness and health screening using science and
technology for early disease detection and managing programmes for
lifestyle intervention based in Bangkok, Thailand.
Finally, the Group signed a Letter of Intent with Marine Group Co.
Ltd. and Salus on collaborative research in the use of genetic
screening tests and formulated cosmetic products containing certain
cell therapy ingredients on the regeneration of skin and hair of
patients. Marine Group is an aesthetic and wellness specialist with
a network of over 42 centres under the brands Slim Up(TM), Skin
Doctors(TM), and Biocell(TM).
The signing ceremony was attended by His Excellency Dato' Jojie
Samuel, Ambassador of Malaysia to Thailand and Encik Mohamed Hafiz
Md Shariff, Trade Commissioner of MATRADE Bangkok.
Chief Executive Officer of Malaysian Genomics, Encik Sasha Nordin,
said, "We are looking forward to a fruitful relationship with our
Thai partners, Salus and Acquest. These collaborations are part of
our strategy of growing our customer base and increasing our
presence overseas through working with business partners who have
an established presence in their respective market segments."
Dr. Roland Neff, CEO of Acquest, said, "This collaboration is the
first step as both parties explore the possibilities of conducting
joint R&D that can result in new products and services that can
be commercialised. We have a state-of-the-art clinical laboratory
in Bangkok and also the largest privately-owned specialty human
cell culturing facility in the country."
Mr. Choy Hong Yang, Director of Salus, said, "At Salus, we use
science and technology to provide services on disease detection,
prevention and life-span improvement. This collaboration with
Malaysian Genomics will enable us to leverage on their genetics
knowledge and expertise to offer more products and services while
the strategic cooperation is in keeping with our core value of
joint innovation to offer new technologies to our customers."
Ms. Songsuda Panich, Founder of Marine Group, said, "Skin Doctor,
Slim Up and BioCell centres are always striving to provide the
latest in skin and aesthetic science and technology for our
customers. We look forward to collaborating with Malaysian Genomics
and with Salus Healthcare on research and development involving
cell regeneration products."
Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC:
MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
Copyright 2022 JCN Newswire . All rights reserved.